Date de publication
Géographie
Langue de la ressource
Texte disponible en version intégrale
Open Access / OK to Reproduce
Évalué par des pairs
L’objectif
This study aims to explore the experiences of patients receiving depot buprenorphine from an Australian publicly operated drug and alcohol service.
Constatations/points à retenir
The majority of participants reported satisfaction with depot buprenorphine across the domains of efficacy, convenience and global satisfaction. Participants perceived benefits as increased convenience, reduced stigmatisation and the inability to ‘skip’ daily Medication Assisted Treatment for Opioid Dependence (MATOD) doses. There were mixed experiences with the ability for depot buprenorphine to ‘hold’ participants throughout the dosing interval. Reduced contact and disconnection from healthcare services were reported as an issue for some participants when initiating depot buprenorphine.
La conception ou méthodologie de recherche
Twenty-eight participants consented to be involved in a mixed methods quantitative verbal survey and qualitative interview process.
